Insights from 2023 ASCO® Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ASCO® Annual Meeting

Breast
Hematology
Lung
GI
GU
GYN
Skin
Head and Neck
Sarcoma
CNS
Basic Science

Playback speed

10 seconds

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cemiplimab to Pembrolizumab in Pts With Completely Resected High-Risk Melanoma"

By Insights from 2023 ASCO® Annual Meeting FEATURING Timothy Panella

739 views

June 8, 2023

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Skin

ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Scenari…

Insights from 2023 ASCO® Annual Meeting

K. Margolin

186 views

ASCO® 2023 Insights: "A Phase 1 Study of Fianlimab (anti-LAG-3) + Ce…

Insights from 2023 ASCO® Annual Meeting

I. Mehmi

97 views

ASCO® 2023 Insights: "Three-Year Data of PRADO and OpACIN-Neo Trials…

Insights from 2023 ASCO® Annual Meeting

I. Reijers

130 views

ASCO® 2023 Insights: "Final Clinical Results & First Translational C…

Insights from 2023 ASCO® Annual Meeting

J. Smithy

53 views

ASCO® 2023 Insights: "Significant Durable Response With Fianlimab & …

Insights from 2023 ASCO® Annual Meeting

O. Hamid

435 views

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cemiplim…

Insights from 2023 ASCO® Annual Meeting

T. Panella

739 views

ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free Surv…

Insights from 2023 ASCO® Annual Meeting

J. Luke

966 views

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on Ovar…

Insights from 2023 ASCO® Annual Meeting

E. Buchbinder

730 views